+

WO1999058184A1 - Instrument medical forme d'alliages de titane beta - Google Patents

Instrument medical forme d'alliages de titane beta Download PDF

Info

Publication number
WO1999058184A1
WO1999058184A1 PCT/US1999/009884 US9909884W WO9958184A1 WO 1999058184 A1 WO1999058184 A1 WO 1999058184A1 US 9909884 W US9909884 W US 9909884W WO 9958184 A1 WO9958184 A1 WO 9958184A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
beta
titanium alloy
alloy composition
guidewire
Prior art date
Application number
PCT/US1999/009884
Other languages
English (en)
Inventor
Barry J. O'brien
Original Assignee
Scimed Life Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scimed Life Systems, Inc. filed Critical Scimed Life Systems, Inc.
Publication of WO1999058184A1 publication Critical patent/WO1999058184A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/02—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02—Inorganic materials
    • A61L31/022—Metals or alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09—Guide wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure

Definitions

  • the present invention relates to improved implantable devices or devices inserted into a body tract or a body cavity of a patient.
  • the present invention relates to an improved material construction for implantable or insertable devices for desired corrosion resistance, material properties and biocompatibility .
  • catheters are known for treating cardiac or other disorders, by temporarily inserting catheters into the vascular system, the urinary tract, or other such tracts, such catheters include angioplasty catheters, which are used to dilate restricted coronary vessels or to treat other ailments. It may well be important that such devices are corrosion resistant, depending upon the environment in which they are used. It is also typically important that such devices be biocompatible.
  • the shaft supporting the catheter have sufficient rigidity for pushability and torqueability, as well as sufficient flexibility to prevent kinks.
  • Prior catheter shafts have been formed of polymer materials, metals, metal alloys such as Nitinol, or have been formed as a hypotube .
  • a hypotube is relatively stiff and provides desired pushability and torqueability, but generally is less flexible and has -2 - increased kinkability.
  • Such hypotubes have typically been formed of a stainless steel material.
  • catheters are conventionally used as well.
  • catheters include infusion catheters, perfusion catheters, drainage catheters, neural catheters, drug delivery catheters, guide catheters, stent delivery catheters, etc...
  • elongate medial devices are used as well. Some such devices include guidewires, atherectomy devices, etc.
  • Other medical devices include implantable devices which are permanently implanted, such as stents and filters. It is important that such medical devices be compatible and also have permanency for extended use in the body cavity environment. Therefore, it is desirable to engineer medical devices for permanent implantation so the devices are formed to withstand adverse implantation environments for long-term wear and durability for long-term treatment success. Additionally, it is important that the material in medical devices be biocompatible with the treatment environment and have sufficient strength for operation and long-term deployment.
  • Stents and filters can be made of stainless steel material, or alternatively, can be made of shape-memory alloys, such as Ni-Ti, or copper-based shape-memory alloys such as Cu-Al-Ni or Cu- Zn-Al.
  • the present invention relates to medical devices adapted for insertion into a patient's body cavity or vasculature, formed of a beta-titanium alloy, having an alloyed composition providing desired operating characteristics for the particular operating environment.
  • a stent is formed of an alloyed beta-titanium composition providing pseudoelastic attributes in a usable operating range for inserting and deploying the stent.
  • an alloyed composition of beta-titanium can be designed to provide superelastic characteristics for desired operating characteristic and elasticity for kink resistance for elongated devices inserted into a body cavity for use.
  • FIGS. 1A-1C illustrate an intravascular procedure for treatment of an occluded vessel and deployment of a stent .
  • FIG. 2 is an embodiment of a stent in accordance with one aspect of the present invention illustrated in a collapsed condition for low profile insertion.
  • FIG. 3 illustrates the stent of FIG. 2 in an expanded deployed position.
  • FIG. 4 illustrates an embodiment of an insertion device for insertion and deployment of an embodiment of a stent of the present invention in a vessel .
  • FIG. 5 illustrates an alternative embodiment of an insertion device for insertion and deployment of an embodiment of a stent of the present invention in a vessel .
  • FIG. 6 illustrates an embodiment of a guidewire in accordance with one aspect of the present invention.
  • FIGS. 7A-7B illustrate an embodiment of an over-the-wire catheter according to one aspect of the present invention. -4 -
  • FIGS. 8A-8B illustrate an embodiment of a single-operator-exchange catheter according to one aspect of the present invention.
  • FIG. 9 illustrates an embodiment of a vena cava filter for trapping blood clots and debris according to one aspect of the present invention.
  • the present invention relates to improved implantable or insertable devices for medical treatment .
  • One embodiment of the present invention relates to an intravascular stent to maintain or hold a dilated vessel in an opened non-occluded condition.
  • Self-expanding or balloon deployable stents are known. Stents may be used and deployed to support various types of body passageways including, for example, esophagus, the intestines, vascular lumens, the ureter, the urethra, as well as other body passageways.
  • FIGS. 1A-1C illustrate a treatment process for an occluded vessel 50.
  • the occluded vessel is initially opened or dilated by known angioplasty techniques as illustrated in FIGS. 1A-1B.
  • a dilatation catheter 52 including a shaft
  • a dilatation balloon 60 is fed through an occluded vessel 50 to locate balloon 60 relative to a lesion 62 (e.g., an occlusion, or a complete restriction) .
  • Balloon 60 is inflated to compress the balloon 60 into the vascular wall 50 (or compress the plaque or occlusion) and expand the vessel wall 50 to open the constriction caused by the stenosis 62 as illustrated by FIG. IB. Thereafter, inflation pressure is released, and the balloon 60 is deflated for withdrawal .
  • a stent 64 may be deployed to retain the - 5 - stenosis 62 in a nonoccluded position.
  • the stent 64 is inserted into the patient and deployed at a treatment site or lesion as illustrated in FIG. 1C to maintain the vessel 50 in an opened nonoccluded position.
  • the stent 64 is inserted in a collapsed condition and is aligned relative to lesion 62. Once, the stent 64 is aligned relative to the lesion 62, the stent 64 is deployed to the deployment diameter illustrated in FIG. 1C. This can be done in any of a variety of ways including methods described herein.
  • FIGS. 2 & 3 illustrate one embodiment of stent 64 in accordance with one aspect of the present invention.
  • Stent 64 is formed of a tubular member 66 constructed of a mesh-like material which is adapted to expand between a low profile insertion dimension as illustrated in FIG. 2, and an expanded dimension for deployment as illustrated in FIG. 3.
  • the stent 64 is sized relative to the body lumen to interact with the vessel walls to maintain the vessel walls in an open, nonoccluded position.
  • the stent be easily expandable and have sufficient rigidity in an expanded deployed state to maintain an occluded vessel
  • the elasticity of the stent should allow flexure of the stent to avoid discomfort to the patient or harm to vessel.
  • the stents are used in body cavities; and, accordingly, it is necessary that the stent be biocompatible with the patient and the body cavity and not react or breakdown in the environment of use .
  • Prior art stents have been made of a stainless steel material which plastically deforms upon sufficient pressure to conform to the vessel wall to hold the vessel wall open for desired blood flow.
  • permanent deformation is achieved when the material is subjected to a force which creates a strain greater than the elastic limit of the material.
  • Exceeding the elastic limit of such materials is believed to compromise the performance of such devices.
  • Other stents are formed of shape-memory alloys which are positioned within the body and deployed via thermal activation to expand the stent and cause it to conform to the opened stenosis.
  • One way and two way shape-memory alloys are known which exhibit shape memory characteristics in a martensite metallurgic phase.
  • Known shape-memory alloys for implantable or insertable medical devices include binary nickel titanium Ni-Ti (nitinol), Ni-Ti-x ("x" being V. Co. Cu. Fe . ) ; Cu-Al-Ni; or Cu-Zn-Al.
  • U.S. 5,562,641, Flomenblit discloses a two way shape memory alloy stent formed of binary nickel titanium Ni-Ti (nitinol), Ni-Ti-x ("x" being V. Co. Cu. Fe . ) ; Cu-Al-Ni; or Cu-Zn-Al.
  • the stent Prior to insertion, the stent is cooled below a transition temperature in the range of -10 to 20 degrees C to transition the stent to a collapsed diameter for insertion.
  • the stent is inserted in a cooled collapsed condition so it can be located at a treatment site.
  • the stent is deployed to an expanded configuration to conform to the treatment organ diameter by heating the stent above a transition temperature of 40-80 degrees C.
  • the stent is again cooled below transition temperature -10 to 20 degrees C to collapse the stent for removal .
  • U.S. Patent No. 5,545,210 discloses an alternate stent design formed of a shape memory alloy such as binary Ni-Ti alloy, Ni-Ti-x or Cu-Al-Ni.
  • the - 7 - stent is collapsed for insertion by mechanically deforming the stent to a collapsed position in the martensite crystalline phase.
  • the stent is deformed in the temperature range below 37 degrees C.
  • the stent is introduced for placement at a treatment site and is heated above body temperature to a transition temperature in a temperature range of 37 -62 degrees C to expand the stent in the austenite condition to the memorialized expanded diameter. Thereafter, the stent cools to body temperature to function in a martensitic condition.
  • the stent may be expanded via application of mechanical pressure via a balloon.
  • Stents are designed to continuously operate in a stenotic vessel to maintain the vessel in a nonoccluded, open condition subsequent to a dilatation operation.
  • tissue grows around the stent so that the stent forms with the vessel wall at the treatment site.
  • the stent be biocompatible with the vessel of the patient. Materials such as titanium provide excellent corrosion resistance to protect the health of the patient. However, other elements may introduce toxins to the patient.
  • the stent is formed of a beta-titanium alloy, such as titanium containing alloyed elements such as molypedenum, zirconium, niobium, tantalum, or iron to provide an alloy with superelastic characteristics in a desired operating range.
  • superelasticity relates to significant strain under constant load with complete elastic recovery for placement and deployment of the stent . - 8 -
  • Beta phase titanium is a body-centered cubic crystalline structure. At room temperature, titanium exists in alpha phase in a closed-packed hexagonal structure. Titanium crystalline structure changes at about 884 degrees C to beta phase. Alloying elements such as copper, chromium, iron, molybdenum, and vanadium beta stabilizers lower the transformation temperature of an alpha phase titanium to a beta phase titanium to remain stable at lower temperatures, even at room temperature. Such beta-titanium alloys generally provide high strength, a relatively low modulus of elasticity, and excellent corrosive resistance for operation in a vascular lumen or other body cavity, such as the esophagus .
  • the stent according to the present invention preferably is formed of a superelastic beta-titanium alloy which has a low modulus of elasticity and elastic recovery in the operating range so that the stent 64 may be easily stretched (as illustrated by arrows F in FIG. 3) for low profile insertion as illustrated in FIG. 2 and elastically recovered to an expanded diameter for deployment as illustrated in FIG. 3.
  • the stent is mechanically crimped to a distal end of a stent deployment apparatus for low-profile insertion. Since the stent is formed of a material with a low modulus of elasticity and is superelastic, stent may be easily stretched to the low-profile dimension and easily mounted in the low-profile dimension without significant tension for low profile insertion and deployment.
  • stent 64 is retained in the low-profile dimension for placement at a deployment site.
  • Stent 64 is deployed at a treatment site by releasing the stress or tension maintaining the stent in a low-profile dimension so that the stent 64 resumes an expanded dimension profile as illustrated in FIG. 3. Since the stent is formed of a superelastic beta- titanium alloy, once the tension is released, the stent elastically returns to its original expanded diameter shape. In the expanded diameter shape shown in FIG. 3, the stent 64 is sized to conform to a vessel wall or cavity wall for operation as illustrated in FIG. lC. The implanted stent-like member allows for a small amount of radial recovery when deflected at low loads as the supported duct or cavity contracts.
  • Beta-titanium alloys have excellent formability, corrosive resistance, and limits certain toxic elements.
  • An example of a beta-titanium alloy comprises the following components, by weight: molybdenum - 8 to 12%; aluminum - 2.5 to 4%; chromium -
  • An alloy with 11% molybdenum; 3% aluminum; 2% vanadium, and 4% niobium, balance titanium is preferred.
  • a number of beta-titanium alloys are available from Memory Corporation of Brookfield, Connecticut.
  • FIGS. 4-5 illustrate alternate embodiments of a stent deployment apparatus for low-profile insertion of stent 64.
  • stent 64 is inserted via a deployment apparatus 70 including a support sheath 72 and an outer deployment sheath 74.
  • Sheath 72 is a tubular member defining a lumen (not shown) extending therethrough for advancement over a guidewire 78.
  • Stent 64 is crimped to and supported about an outer diameter - 10 - of sheath 72 in a low-profile dimension.
  • Sheath 74 is formed of a tubular member having a central lumen 80 sized to extend about sheath 72 and low-profile stent 64 to retain the stent in the low-profile dimension.
  • sleeve or sheath 74 is withdrawn proximally from stent 64 as illustrated by arrow 82 to release the compression force to stent 64 so that stent 64 elastically recovers to its original expanded diameter. Once the radial pressure is released, the stent elastically recovers, or "springs,” to its original pre-stressed expanded profile for deployment as illustrated in FIG. 1C.
  • a distal end of sheath 74 extends about stent 64 supported at the distal end of sheath 72 to maintain stent 64 in a collapsed low profile for insertion. Thereafter, sheath 74 is withdrawn for deployment of stent 64. The stent 64 is inserted and advanced to a deployment site via apparatus 70 as illustrated in FIG. 4 while sleeve or sheath 74 maintains stent in a collapsed low profile for insertion.
  • FIG. 5 An alternate deployment apparatus 84 is illustrated in FIG. 5.
  • device 84 is formed of a tubular member having an inner lumen 86, a proximal end (not shown) and a distal end 88.
  • Tubular member includes a first diameter portion 90 at distal end 88, and a second diameter portion 92 supporting ring tab 94 extending distally from an end of the second diameter portion 92 and opened at a distal end.
  • the stent 64 is supported at a distal end 88 of first diameter portion 90 in the collapsed profile.
  • normally expanded stent is stretched and crimped down about first diameter portion 90.
  • Ring tab 94 extends about a portion of collapsed stent 64.
  • An - 11 - inner diameter of ring tab 94 is sized to retain stent in a crimped low profile.
  • stent 64 is advanced via apparatus 84 to a deployment site for deployment. Once stent 64 is positioned at a deployment site, apparatus 84 is withdrawn proximally as illustrated by arrow 96. As apparatus 84 is withdrawn proximally, stent 64 slides off portion 90 through an end opening 90 of tab 94 so that tab 94 no longer maintains stent 64 in the collapsed profile and stent elastically recovers and expands to conform to the profile of the lumen of the vessel at the deployment site.
  • example deployment devices are shown, it should be understood that alternate deployment devices may be used including balloon-type deployment devices and the invention is not limited to any particular deployment device .
  • FIGS. 2-3 illustrate a particular embodiment of a stent
  • the invention is not limited to the particular design shown, and alternate stent embodiments may be employed such as for example, a coil stent, a tubular stent or a tubular stent having perforations for expansion.
  • the stent is not limited to any particular stent and that stents of the present invention may be used in many body cavities or tracts, such as the coronary vessels, esophagus, or urinary or urethral tracks where the operating environment is acidic or corrosive and enhanced corrosive resistance is desired.
  • Guidewires are known and are typically used for medical treatment to aid with insertion and placement of medical devices.
  • Guidewires may be formed of a solid core wire or a solid core wire surrounded by a coiled wire, or a tubular member. Hollow guidewires - 12 - can also be used for drug delivery, to take pressure measurements, and to support distal protection or other devices. In particular, guidewires may be used in an angioplasty procedure to guide a dilatation catheter to a treatment site or in gastrointestinal procedures to accomplish a number of tasks. When used for coronary or intraluminal procedures, it is desirable that the guidewire have a small diameter, a smooth finish, and have desirable pushability, torqueability and kink resistance. When used in gastrointestinal procedures, guidewires preferably have high corrosion resistance.
  • Pushability refers to the ability of the wire to transfer axial force applied to the proximal end for placement of the guidewire.
  • Torqueability relates to the ability of the guidewire to transfer torque or rotation along the length of the guidewire for manipulating the guidewire for placement at a treatment site and is related to the torsional rigidity of the guidewire.
  • Kink resistance is the measure of the ability of a guidewire to be forced into a relatively tight bend radius without permanently deforming the wire . In order to steer a guidewire through a tortuous vessel, sufficient kink resistance is desired so that the device does not kink or permanently deform, thus degrading trackability and operation of the guidewire through a patient's vascular system.
  • FIG. 6 illustrates an embodiment of a guidewire 100 of the present invention.
  • the guidewire 100 includes an elongated constant diameter core portion 102, a transitional portion 106, and a flexible distal tip 108, and is relatively stiff and rigid for adequate - 13 - pushability.
  • Relatively flexible distal tip is preferably formed of an elastic more flexible cylindrical member so that the tip of the guidewire bends under small loads to navigate through tortuous vessels to a treatment site.
  • the guidewire (core portion 102, transition portion 106, and distal tip 108) is preferably formed of a beta-titanium alloy which has superelastic properties.
  • the superelastic characteristic properties provide desirable kink resistance.
  • the superelastic or pseudoelastic properties allow the guidewire to be pushed into a tight bend and to absorb force without permanent deformation.
  • superelasticity allows relatively large strain at a constant load for tracking a guidewire through a tortuous vascular system.
  • the guidewire may be readily bent and straightened without deformation to reduce resistance to advancement of the guidewire .
  • Core portion 102 is formed of a solid cylindrical member having a sufficient diameter to provide rigidity for advancing the guidewire .
  • Flexible tip 108 is sized smaller than core portion 102 to provide a flexible tip which can be forced into tight bends for navigation. As previously explained, flexible tip 108 is straightened after force is released for continued operation. Transition portion 106 is an elongated tapered member to provide a gradual connection between the larger, more rigid core portion 102 and the smaller, more flexible tip 108.
  • Distal tip 108 is preferably formed of a beta- titanium alloy having a relatively low modulus of elasticity to deform at low loads so that the distal tip 108 may be easily bent to curve through blood vessels in - 14 - order to wind to a treatment site.
  • core portion 102 may be formed of a beta-titanium having a higher modulus of elasticity for pushability and trackability of the guidewire 100.
  • the distal tip is shaped or preformed for insertion in any number of known shapes such as an "R" shape, "J" shape or other shapes.
  • the beta-titanium alloy guidewire may be coated with a polymer coating such as polytetrafluoroethylene (PTFE) .
  • PTFE polytetrafluoroethylene
  • the guidewire described has desired operating characteristics for inserting the guidewire through a patient's vasculature for tracking the guidewire to a treatment site and is formed for biocompatibility with the operating environment.
  • the core member 102 and distal tip 108 are formed of a beta-titanium alloy, the invention is not so limited and the guidewire may be formed of a composite structure .
  • catheters for treating medical ailments and are inserted in a patient for treatment.
  • such devices include vascular catheters and other catheters (mentioned in the background portion of the specification) formed of elongated tubular members which are advanced through a patient .
  • the tubular members may be formed of a plastic material or may be a stainless steel hypotube.
  • Vascular catheters are advanced a sufficient distance to a treatment site and must have pushability, torqueability, and kink resistance for suitable operation. - 15 -
  • FIGS. 7A-7B and 8A-8B illustrate vascular catheters 120 and 122 adapted for use as dilatation catheters.
  • FIGS 7A-7B illustrate an over-the-wire catheter 120 having a catheter shaft 123, a proximal manifold 124 and a distal dilatation balloon 126.
  • a guidewire 100 extends through the catheter 120 to track the catheter 120 to a treatment site in a known manner.
  • Manifold 124 includes an inflation port 128, a guidewire port 130 and a flush port 132. As illustrated in FIG. 7B, the catheter shaft
  • the inner tube 134 or outer tube 136 (or both) is formed of a beta-titanium material.
  • the beta-titanium material has a relatively low modulus of elasticity and pseudoelastic characteristics for tracking through tortuous vascular without permanent bending or deformation.
  • tubes 134, 136 may be formed of a composite (polymer/alloy) structure to provide desired rigidity and flexibility along the length of the catheter to track the catheter to the treatment site as disclosed in U.S. Patent No. 5,549,552, Peters et al . which is hereby incorporated by reference, the alloy portion of which is formed of beta-titanium in accordance with the present invention.
  • FIGS. 8A-8B illustrate a single-operator- exchange catheter 122 including a distal guidewire lumen 144.
  • Catheter 122 includes shaft 146, manifold 148 and - 16 - balloon 150.
  • Manifold 148 includes an inflation lumen for inflating balloon 150 at the distal end.
  • shaft 146 is formed of elongated tubular extent 152 having an inflation lumen 154 extending therethrough.
  • a distal portion of the shaft 146 is formed of an inner tube 156 forming the guidewire lumen 144 extending along a distal extent of the catheter and an outer tube 158 enclosing inner tube 156 and coupled to proximal tubular extent 152.
  • Tubular extent 152 or inner or outer tubes 156, 158 are formed of a beta-titanium alloy.
  • the beta-titanium alloy has pseudoelastic characteristics and for providing desired kink resistance, as well as allowing the catheter 122 to pseudoelastically deform under constant load for tracking catheter 122 to a treatment site .
  • vena cava filter 160 for trapping blood clots in a vessel, an embodiment of which is illustrated in FIG. 8 may be formed of a beta-titanium alloy. Vena cava filter 160 can be collapsible for insertion and expandable for deployment .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

On insère un instrument médical amélioré (64, 100, 120, 122, 160) dans une cavité de l'organisme d'un patient à des fins thérapeutiques. L'instrument médical (64, 100, 120, 122, 160) est formé d'une composition d'un alliage de titane bêta, conçue pour lui conférer les caractéristiques de fonctionnement désirées dans l'environnement d'utilisation, sur la base de l'utilisation dudit instrument.
PCT/US1999/009884 1998-05-08 1999-05-05 Instrument medical forme d'alliages de titane beta WO1999058184A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7478598A 1998-05-08 1998-05-08
US09/074,785 1998-05-08

Publications (1)

Publication Number Publication Date
WO1999058184A1 true WO1999058184A1 (fr) 1999-11-18

Family

ID=22121676

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/009884 WO1999058184A1 (fr) 1998-05-08 1999-05-05 Instrument medical forme d'alliages de titane beta

Country Status (1)

Country Link
WO (1) WO1999058184A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002094334A1 (fr) * 2001-05-21 2002-11-28 Medtronic, Inc. Dispositif medical allonge malleable
US7101391B2 (en) 2000-09-18 2006-09-05 Inflow Dynamics Inc. Primarily niobium stent
US7402173B2 (en) 2000-09-18 2008-07-22 Boston Scientific Scimed, Inc. Metal stent with surface layer of noble metal oxide and method of fabrication
US8349249B2 (en) 2003-02-10 2013-01-08 Heraeus Precious Metals Gmbh & Co. Kg Metal alloy for medical devices and implants
US8382739B2 (en) * 2003-12-02 2013-02-26 Boston Scientific Scimed, Inc. Composite medical device and method of forming
EP2210627A3 (fr) * 2002-03-22 2014-05-21 Boston Scientific Limited Stent compatible avec IRM et rayons X

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238004A (en) * 1990-04-10 1993-08-24 Boston Scientific Corporation High elongation linear elastic guidewire
US5545210A (en) * 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5562641A (en) * 1993-05-28 1996-10-08 A Bromberg & Co. Ltd. Two way shape memory alloy medical stent
US5782907A (en) * 1995-07-13 1998-07-21 Devices For Vascular Intervention, Inc. Involuted spring stent and graft assembly and method of use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238004A (en) * 1990-04-10 1993-08-24 Boston Scientific Corporation High elongation linear elastic guidewire
US5562641A (en) * 1993-05-28 1996-10-08 A Bromberg & Co. Ltd. Two way shape memory alloy medical stent
US5545210A (en) * 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5782907A (en) * 1995-07-13 1998-07-21 Devices For Vascular Intervention, Inc. Involuted spring stent and graft assembly and method of use

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101391B2 (en) 2000-09-18 2006-09-05 Inflow Dynamics Inc. Primarily niobium stent
US7402173B2 (en) 2000-09-18 2008-07-22 Boston Scientific Scimed, Inc. Metal stent with surface layer of noble metal oxide and method of fabrication
US7604703B2 (en) 2000-09-18 2009-10-20 Boston Scientific Scimed, Inc. Primarily niobium stent
WO2002094334A1 (fr) * 2001-05-21 2002-11-28 Medtronic, Inc. Dispositif medical allonge malleable
EP2210627A3 (fr) * 2002-03-22 2014-05-21 Boston Scientific Limited Stent compatible avec IRM et rayons X
US7582112B2 (en) 2003-02-10 2009-09-01 Boston Scientific Scimed, Inc. Metal stent with surface layer of noble metal oxide and method of fabrication
US8349249B2 (en) 2003-02-10 2013-01-08 Heraeus Precious Metals Gmbh & Co. Kg Metal alloy for medical devices and implants
US8403980B2 (en) 2003-02-10 2013-03-26 Heraeus Materials Technology Gmbh & Co. Kg Metal alloy for medical devices and implants
US8382739B2 (en) * 2003-12-02 2013-02-26 Boston Scientific Scimed, Inc. Composite medical device and method of forming

Similar Documents

Publication Publication Date Title
JP5020461B2 (ja) 改善された放射線不透過性腔内医療装置
US5456667A (en) Temporary stenting catheter with one-piece expandable segment
JP5208641B2 (ja) 隣接フープを接続するための湾曲ブリッジを有する脈間内ステント
EP1365830B1 (fr) Systeme de fil-guide pour occlusion totale
JP4722378B2 (ja) 放射線不透過性内腔内医療装置
US5964771A (en) Temporary stent system
US6090115A (en) Temporary stent system
US5573509A (en) Catheter with an expandable perfusion slit
US6419693B1 (en) High strength member for intracorporeal use
EP1511532B1 (fr) Fils-guides de protection distaux specialises
US5573508A (en) Catheter with an expandable perfusion lumen
EP1366732B1 (fr) Système de mise en place d'un stent avec un fil-guide fixe
US8360995B2 (en) Wire guide
US6440162B1 (en) Stent having increased scaffolding expandable bar arms
US20080269641A1 (en) Method of using a guidewire with stiffened distal section
US20070239259A1 (en) Nitinol alloy design and composition for medical devices
KR20020030023A (ko) 향상된 형상 유지능력을 가진 카테터
US20110152994A1 (en) Implantable device
JPH1119218A (ja) 成形可能な先端を備えた超弾性ガイドワイヤ
WO2002005886A1 (fr) Element de transition de rigidite pour fil-guide
WO2001045787A1 (fr) Fil guide composite avec une construction en tube etire et rempli
JP4541008B2 (ja) アンビルブリッジ・ステントデザイン
US20050119727A1 (en) High strength member for intracorporeal use
JP2006507084A (ja) ステント送給及び保持装置
JP4667758B2 (ja) スプリットブリッジ・ステントデザイン

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载